Cantourage Group (HIGH) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
23 Jun, 2026Executive summary
Achieved a net profit of €210,989.14 for H1 2024, up from €28,531.04 in H1 2023.
Revenue increased to €898,038.78 in H1 2024 from €599,151.83 year-over-year.
Main revenues stem from internal service contracts with subsidiaries.
Financial highlights
Total assets at June 30, 2024: €45,476,315.99, up from €45,089,637.69 at June 30, 2023.
Equity increased to €44,468,380.10 from €44,257,390.96 year-over-year.
Personnel expenses rose to €468,421.23 from €335,879.83 year-over-year.
Other operating income includes €153,369.74 from reversal of provisions.
Outlook and guidance
No significant off-balance sheet obligations or financial commitments reported.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Cantourage Group
- Premium focus lifted Q2 EBITDA 45% YoY despite a 22% revenue decline.HIGH
Company presentation - Q3 EBITDA turned positive as higher margins and international markets offset German pricing pressure.HIGH
Q3 2026 - Profitable, asset-light cannabis platform drives growth with innovation, telemedicine, and strong margins.HIGH
Company presentation - EBITDA up 45% in Q2 2026 as high-margin focus boosts profitability and international growth.HIGH
Q2 2026 - Revenue and net income grew strongly, with all earnings retained and a clean audit opinion.HIGH
H2 2024 - Q1 2025 revenue soared to EUR 25.6 million, quadrupling year-over-year on robust European demand.HIGH
Q1 2025 TU - Profitable, asset-light cannabis platform drives growth with innovation and telemedicine.HIGH
Investor presentation - Revenue and profit fell, but equity and liquidity remain robust amid higher compliance costs.HIGH
H1 2025 - Q2 2025 revenue more than doubled year-over-year, exceeding last year's total annual sales.HIGH
Q2 2025 TU